Thrivent Financial for Lutherans’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$396K Buy
23,140
+744
+3% +$12.7K ﹤0.01% 2229
2025
Q1
$1.43M Sell
22,396
-616,936
-96% -$39.4M ﹤0.01% 1476
2024
Q4
$77.7M Buy
639,332
+14,444
+2% +$1.76M 0.15% 184
2024
Q3
$78M Sell
624,888
-19,787
-3% -$2.47M 0.15% 198
2024
Q2
$102M Buy
644,675
+37,940
+6% +$5.99M 0.21% 124
2024
Q1
$78.5M Sell
606,735
-221,973
-27% -$28.7M 0.16% 177
2023
Q4
$79.9M Buy
828,708
+197,747
+31% +$19.1M 0.17% 163
2023
Q3
$76.5M Buy
630,961
+572,537
+980% +$69.4M 0.18% 151
2023
Q2
$6.69M Sell
58,424
-517,095
-90% -$59.2M 0.02% 757
2023
Q1
$79.3M Sell
575,519
-130,583
-18% -$18M 0.19% 151
2022
Q4
$91.5M Buy
706,102
+6,619
+0.9% +$858K 0.24% 107
2022
Q3
$77.3M Buy
699,483
+584,654
+509% +$64.6M 0.21% 123
2022
Q2
$8.61M Sell
114,829
-4,064
-3% -$305K 0.02% 660
2022
Q1
$9.29M Sell
118,893
-2,756
-2% -$215K 0.02% 703
2021
Q4
$11M Buy
121,649
+17,266
+17% +$1.55M 0.02% 644
2021
Q3
$9.65M Buy
104,383
+228
+0.2% +$21.1K 0.02% 678
2021
Q2
$8.1M Buy
104,155
+59,111
+131% +$4.6M 0.02% 750
2021
Q1
$3.36M Sell
45,044
-10,117
-18% -$754K 0.01% 1100
2020
Q4
$9.41M Buy
55,161
+9,465
+21% +$1.61M 0.02% 667
2020
Q3
$6.42M Sell
45,696
-1,193
-3% -$168K 0.02% 724
2020
Q2
$7.52M Buy
46,889
+190
+0.4% +$30.5K 0.02% 617
2020
Q1
$4.57M Buy
46,699
+196
+0.4% +$19.2K 0.02% 682
2019
Q4
$6M Buy
46,503
+10,041
+28% +$1.3M 0.02% 691
2019
Q3
$2.75M Buy
+36,462
New +$2.75M 0.01% 848
2018
Q1
Sell
-9,000
Closed -$501K 2032
2017
Q4
$501K Buy
+9,000
New +$501K ﹤0.01% 1689
2014
Q3
Sell
-13,210
Closed -$394K 1883
2014
Q2
$394K Buy
+13,210
New +$394K ﹤0.01% 1243